CONSULTING AGREEMENTConsulting Agreement • May 27th, 2021 • Context Therapeutics Inc. • Pharmaceutical preparations • Pennsylvania
THIS CONSULTING AGREEMENT (“Agreement”) is made and entered into on February 25, 2021 by and between Evan G. Dick, PhD (“Consultant”), and Context Therapeutics LLC, a Delaware limited liability company (“Company”).
CONFIDENTIAL TREATMENT REQUESTED - REDACTED COPY AMENDMENT NO. 1 TO PROCESS DEVELOPMENT AGREEMENTProcess Development Agreement • May 27th, 2021 • Context Therapeutics Inc. • Pharmaceutical preparations
This AMENDMENT NO. 1 TO PROCESS DEVELOPMENT AGREEMENT (this “Amendment”) is effective as of this 21st day of April, 2021 (the “Amendment Effective Date”), and is entered into by and between Tyligand Bioscience (Shanghai) Limited, having its registered office at 3728 Jinke Road, Building 1 West Wing, ZhangJiang Hitech Park, Shanghai, China (“Tyligand”) and Context Therapeutics LLC, a Delaware limited liability company having its registered office at 3675 Market Street, Suite 200, Philadelphia, PA 19104 (“Context”). Tyligand and Context are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Context Therapeutics Inc. Stock Grant AgreementStock Grant Agreement • May 27th, 2021 • Context Therapeutics Inc. • Pharmaceutical preparations
CONFIDENTIAL TREATMENT REQUESTED - REDACTED COPY PROCESS DEVELOPMENT AGREEMENTProcess Development Agreement • May 27th, 2021 • Context Therapeutics Inc. • Pharmaceutical preparations • New York
This PROCESS DEVELOPMENT AGREEMENT (“Agreement”) is made on this 6th day of March, 2020 (“Effective Date”) by and between Context Therapeutics LLC, a Delaware limited liability company having its registered office at 3675 Market Street, Suite 200, Philadelphia, PA 19104(“Context”); and Tyligand Bioscience (Shanghai) Limited, A having its registered office at 781 Cailun Road, ZhangJiang Hitech Park, Shanghai. China (“Tyligand”). Context and Tyligand may be referred to individually as a “Party” or jointly as “Parties”.
Context Therapeutics Inc. Stock Option AgreementStock Option Agreement • May 27th, 2021 • Context Therapeutics Inc. • Pharmaceutical preparations
CONSULTING AGREEMENTConsulting Agreement • May 27th, 2021 • Context Therapeutics Inc. • Pharmaceutical preparations • Pennsylvania
THIS CONSULTING AGREEMENT (the “Agreement”), dated as of May 7, 2021 (the “Effective Date”), is made by and between Context Therapeutics Inc., Delaware corporation (“Company”), and OncoStrategy, LLC, with its registered address at 4203 Greenspire Lane, New Hope, PA 18938 (hereinafter “you” or “Consultant’’).
